SCHEMBL8109466

SCHEMBL8109466

OC[C@H]1CC=C[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8079693 1.00
SCHEMBL191431 1.00
SCHEMBL9792876 1.00
SCHEMBL8109464 1.00
SCHEMBL11007855 0.83 GBA2 (0.30)
SCHEMBL6857765 0.83 GBA2 (0.30)
SCHEMBL19174844 0.80
SCHEMBL19136724 0.80
SCHEMBL15024141 0.77
SCHEMBL1973814 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9683003-B2 Heteroaryl compounds useful as inhibitors of SUMO activating enzyme MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-1032573-A1 PROCESS FOR PREPARING A CHIRAL NUCLEOSIDE ANALOGUE GLAXO GROUP LIMITED (GB) 2000-09-06 EP disclosed
WO-1999024431-A1 PROCESS FOR PREPARING A CHIRAL NUCLEOSIDE ANALOGUE GLAXO GROUP LIMITED (GB) 1999-05-20 WO disclosed
WO-1999021861-A1 PROCESS FOR PREPARING A CHIRAL NUCLEOSIDE ANALOGUE GLAXO GROUP LIMITED (GB) 1999-05-06 WO disclosed
US-5063233-A Cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1991-11-05 US disclosed
US-4954504-A Hypotensive agents, psychotic disorders CIBA-GEIGY CORPORATION (US) 1990-09-04 US disclosed
EP-0267878-A1 N9-cyclopentyl-substituted adenine derivatives CIBA-GEIGY AG (CH) 1988-05-18 EP disclosed